blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2870152

EP2870152 - AMIDE OR UREA SUBSTITUTED BENZOTHIAZOLE DERIVATIVES AS INHIBITORS OF ENDOTHELIAL LIPASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.08.2017
Database last updated on 02.08.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[2015/20]
Inventor(s)01 / PI, Zulan
c/o Bristol-Myers Squibb Company
311 Pennington-Rocky Hill Road
Pennington, New Jersey 08534 / US
02 / QIAO, Jennifer X.
c/o Bristol-Myers Squibb Company
311 Pennington-Rocky Hill Road
Pennington, New Jersey 08534 / US
03 / TORA, George O.
c/o Bristol-Myers Squibb Company
311 Pennington-Rocky Hill Road
Pennington, New Jersey 08534 / US
04 / WANG, Tammy C.
c/o Bristol-Myers Squibb Company
311 Pennington-Rocky Hill Road
Pennington, New Jersey 08534 / US
 [2015/20]
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2015/20]Reitstötter Kinzebach
Patentanwälte
Sternwartstrasse 4
81679 München / DE
Application number, filing date13737767.703.07.2013
[2016/39]
WO2013US49194
Priority number, dateUS201261669266P09.07.2012         Original published format: US 201261669266 P
[2015/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014011461
Date:16.01.2014
Language:EN
[2014/03]
Type: A1 Application with search report 
No.:EP2870152
Date:13.05.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 16.01.2014 takes the place of the publication of the European patent application.
[2015/20]
Type: B1 Patent specification 
No.:EP2870152
Date:28.09.2016
Language:EN
[2016/39]
Search report(s)International search report - published on:EP16.01.2014
ClassificationIPC:C07D417/06, C07D417/14, A61K31/428, A61K31/4439, A61K31/515, A61P3/06, A61P9/10, A61P9/12, A61P25/28
[2015/20]
CPC:
C07D417/14 (EP,US); A61P25/28 (EP); A61P3/06 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D417/06 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/20]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:AMID- ODER HARNSTOFF-SUBSTITUIERTE BENZOTHIAZOLDERIVATE ALS INHIBITOREN VON ENDOTHELLIPASE[2016/14]
English:AMIDE OR UREA SUBSTITUTED BENZOTHIAZOLE DERIVATIVES AS INHIBITORS OF ENDOTHELIAL LIPASE[2015/20]
French:DÉRIVÉS DE BENZOTHIAZOLE SUBSTITUÉES PAR UN GROUPE D'AMIDE OU D'URÉE EN TANT QU'INHIBITEURS DE LA LIPASE ENDOTHÉLIALE[2016/14]
Former [2015/20]AMID- ODER HARNSTOFFSUBSTITUIERTE BENZOTHIAZOLDERIVATE ALS ENDOTHELLIPASEHEMMER
Former [2015/20]DÉRIVÉS DE BENZOTHIAZOLE SUBSTITUÉS PAR AMIDE OU URÉE EN TANT QU'INHIBITEURS DE LIPASE ENDOTHÉLIALE
Entry into regional phase03.02.2015National basic fee paid 
03.02.2015Designation fee(s) paid 
03.02.2015Examination fee paid 
Examination procedure03.02.2015Examination requested  [2015/20]
28.09.2015Amendment by applicant (claims and/or description)
19.04.2016Communication of intention to grant the patent
16.08.2016Fee for grant paid
16.08.2016Fee for publishing/printing paid
16.08.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.04.2016
Opposition(s)29.06.2017No opposition filed within time limit [2017/36]
Fees paidRenewal fee
10.07.2015Renewal fee patent year 03
11.07.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.07.2013
AL28.09.2016
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
MK28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
TR28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
[2020/15]
Former [2019/51]HU03.07.2013
AL28.09.2016
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
MK28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2019/47]HU03.07.2013
AL28.09.2016
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2019/31]HU03.07.2013
AL28.09.2016
AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2019/30]AL28.09.2016
AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2018/47]AL28.09.2016
AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/52]AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/34]AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/32]AT28.09.2016
BE28.09.2016
CZ28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/13]FI28.09.2016
HR28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
RS28.09.2016
SE28.09.2016
NO28.12.2016
GR29.12.2016
Former [2017/11]FI28.09.2016
HR28.09.2016
LT28.09.2016
RS28.09.2016
SE28.09.2016
NO28.12.2016
GR29.12.2016
Former [2017/10]FI28.09.2016
HR28.09.2016
LT28.09.2016
RS28.09.2016
SE28.09.2016
NO28.12.2016
Former [2017/09]FI28.09.2016
LT28.09.2016
NO28.12.2016
Former [2017/07]LT28.09.2016
Cited inInternational search[A]CA2784710  (SHIONOGI & CO [JP]) [A] 1-12 * claim 1 *;
 [AD]WO2012081563  (SHIONOGI & CO [JP], et al) [AD] 1-12* claim 1 *
by applicantWO9932611
 WO2004093872
 WO2004094393
 WO2004094394
 US2006211755
 WO2007042178
 US7217727
 WO2007110215
 WO2007110216
 US2008287448
 US2009054478
 US2009076068
 US7595403
 WO2009123164
 WO2009133834
 WO2010044441
 WO2011074560
 US2011251386
 WO2012081563
 US2012253040
 WO2012173099
    - ROSS, R., NATURE, (1993), vol. 362, no. 6423, pages 801 - 809
    - GORDON, D.J. ET AL., N. ENGL. J. MED., (1989), vol. 321, no. 19, pages 1311 - 1316
    - JIN, W. ET AL., TRENDS ENDOCRINOL. METAB., (2002), vol. 13, no. 4, pages 174 - 178
    - WONG, H. ET AL., J. LIPID RES., (2002), vol. 43, pages 993 - 999
    - HIRATA, K. ET AL., J. BIOL. CHEM., (1999), vol. 274, no. 20, pages 14170 - 14175
    - JAYE, M. ET AL., NAT. GENET., (1999), vol. 21, pages 424 - 428
    - MCCOY, M.G., J. LIPID RES., (2002), vol. 43, pages 921 - 929
    - WIDDER, K. ET AL.,, Methods in Enzymology, ACADEMIC PRESS, (1985), vol. 112, pages 309 - 396
    - "Design and Application of Prodrugs", BUNDGAARD, H. ET AL., A Textbook of Drug Design and Development, HARWOOD ACADEMIC PUBLISHERS, (1991), pages 113 - 191
    - BUNDGAARD, H., ADV. DRUG DELIV. REV., (1992), vol. 8, pages 1 - 38
    - BUNDGAARD, H. ET AL., I PHARM. SCI., (1988), vol. 77, page 285
    - KAKEYA, N. ET AL., CHEM. PHARM. BULL., (1984), vol. 32, page 692
    - "Prodrugs and Targeted Delivery", Methods and Principles in Medicinal Chemistry, WILEY-VCH, (2011), vol. 47
    - FOLKMAN, J. ET AL., SCIENCE, (1987), vol. 235, pages 442 - 447
    - YANAGISAWA, M. ET AL., NATURE, (1988), vol. 332, no. 6163, pages 411 - 415
    - FOLKMAN, J. ET AL., J. BIOL. CHEM., (1992), vol. 267, no. 16, pages 10931 - 10934
    - JANSSENS, S.P. ET AL., J. BIOL. CHEM., (1992), vol. 267, no. 21, pages 14519 - 14522
    - LAMAS, S. ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1992), vol. 89, no. 14, pages 6348 - 6352
    - LUSCHER, T.F. ET AL., HYPERTENSION, (1992), vol. 19, no. 2, pages 117 - 130
    - WILLIAMS ET AL., AM. REV. RESPIR. DIS., (1992), vol. 146, pages S45 - S50
    - BEVILACQUA, M.P. ET AL., J. CLIN. INVEST., (1993), vol. 91, no. 2, pages 379 - 387
    - CIRCULATION, (2012), vol. 125, pages E2 - E220
    - GORDON, D.J. ET AL., CIRCULATION, (1989), vol. 79, no. 1, pages 8 - 15
    - DELEMOS, A.S. ET AL., CIRCULATION, (2002), vol. 106, no. 11, pages 1321 - 1326
    - STRAUSS, J.G. ET AL., BIOCHEM. J., (2002), vol. 368, pages 69 - 79
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.